Laborie Medical Technologies Sets Sights on Obstetrics with JADA System Acquisition from Organon

Laborie Announces Acquisition of JADA System from Organon

Laborie Medical Technologies Corp., a major player in the medical technology field, has officially announced its agreement to acquire the innovative JADA® System from Organon. This acquisition represents a significant step in Laborie’s effort to bolster its obstetrics portfolio and enhance maternal health solutions globally. The JADA System is an FDA-cleared device that addresses abnormal postpartum uterine bleeding, a critical concern during childbirth. With the device already launched in over 20 countries and utilized in more than 2,000 hospitals across the United States, Laborie aims to further expand its reach and impact in the healthcare sector.

The transaction is valued at up to $465 million, comprising an upfront payment of $440 million upon closure, and a milestone payment of an additional $25 million dependent on achieving certain revenue targets in 2026. Anticipated to close in the first quarter of 2026, the acquisition is subject to standard regulatory approvals and closing conditions.

Chris Smith, President and CEO of Laborie, emphasized the personal nature of childbirth and the need for comprehensive support for mothers. He stated, "The JADA System helps care teams provide treatment when it matters most, and being part of that mission is something we hold with deep pride and purpose at Laborie." This acquisition is expected to not only enhance Laborie’s product offerings but also fortify its commitment to obstetric care, a mission that resonates deeply within the organization.

Joseph Morrissey, interim CEO of Organon, reflected on the JADA team’s accomplishments, noting how they have made a significant impact on over 136,000 mothers in various countries. He expressed confidence that Laborie, with its strong foundations in maternal health technologies, is well-positioned to advance the availability and recognition of the JADA System as a standard care option for postpartum hemorrhage management.

Patricia Industries, part of Investor AB and an owner of Laborie, also welcomes the JADA system. Sofia Gerard, Principal at Patricia Industries, stated that the addition reinforces Laborie’s mission to enhance maternal health outcomes worldwide, complementing their existing portfolio of technologies in this field.

The commitment to enhancing maternal care through innovative medical technology marks a pivotal moment for Laborie and reinforces its dedication to providing effective solutions that benefit caregivers and mothers globally. The planned acquisition not only brings a valuable asset under Laborie's wing but also signals an invigorated focus on addressing critical healthcare needs in obstetrics.

In conclusion, the acquisition of the JADA System highlights Laborie's strategic approach to expanding its technological capabilities in maternal health. The company’s commitment to improving outcomes and accessibility in obstetric care signifies its ongoing effort to affect positive change in the medical community. As the negotiations progress towards closure in 2026, the anticipation surrounding the integration of JADA into Laborie’s offerings continues to build, promising a brighter future for maternal care across various regions.

About Laborie Medical Technologies

Founded and headquartered in Portsmouth, New Hampshire, Laborie specializes in medical technologies targeting the fields of Urology, Gastroenterology, and Obstetrics. The company is dedicated to providing high-quality diagnostic and therapeutic products that prioritize patient dignity and enhance healthcare experiences. Through partnerships and acquisitions, Laborie continues to expand its influence and portfolio in the medical technology sector, driving forward with a mission focused on impactful innovations that serve both clinicians and patients alike.

About Organon

As a global healthcare company, Organon aims to deliver meaningful medicines and healthcare solutions that improve the everyday lives of people. In collaboration with teams like JADA, Organon continues to influence safe and effective health management practices.

This acquisition stands as a testament to Laborie's ambitious vision and commitment to transforming the landscape of maternal care worldwide.